TherapeuticsMD | 10-K/A: Annual report (Amendment)
17:05 ET
TherapeuticsMD | 10-K: Annual report
Mar 29 16:35 ET
TherapeuticsMD | 8-K: Current report
Mar 29 16:33 ET
TherapeuticsMD | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Walker Marlan D
Dec 7, 2023 16:51 ET
TherapeuticsMD | 144: Notice of proposed sale of securities pursuant to Rule 144
Dec 6, 2023 11:36 ET
TherapeuticsMD | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Rubric Capital Management LP(25.73%),David Rosen(25.73%)
Nov 17, 2023 09:28 ET
TherapeuticsMD | 4: Statement of changes in beneficial ownership of securities-Director Rubric Capital Management LP
Nov 17, 2023 09:27 ET
TherapeuticsMD: Q3 2023 Earnings Report
Nov 14, 2023 16:31 ET
TherapeuticsMD | 8-K: TherapeuticsMD Announces Third Quarter 2023 Financial Results
Nov 14, 2023 16:25 ET
TherapeuticsMD | 4: Statement of changes in beneficial ownership of securities-Officer ZIEGLER JOSEPH
Aug 21, 2023 16:22 ET
TherapeuticsMD | 3: Initial statement of beneficial ownership of securities-Officer ZIEGLER JOSEPH
Aug 21, 2023 16:20 ET
TherapeuticsMD | 8-K: Current report
Aug 18, 2023 17:18 ET
TherapeuticsMD | 10-Q: Q2 2023 Earnings Report
Aug 14, 2023 07:30 ET
TherapeuticsMD | 8-K: TherapeuticsMD Announces Second Quarter 2023 Financial Results
Aug 14, 2023 07:15 ET
TherapeuticsMD | 4: Statement of changes in beneficial ownership of securities-Director Thompson Tommy G
Jul 19, 2023 17:29 ET
TherapeuticsMD | 4: Statement of changes in beneficial ownership of securities-Director Naughton Gail K
Jul 19, 2023 17:28 ET
TherapeuticsMD | 4: Statement of changes in beneficial ownership of securities-Director Collins Cooper C.
Jul 19, 2023 17:27 ET
TherapeuticsMD | D: Filing D
Jul 10, 2023 17:49 ET
TherapeuticsMD | 8-K: Current report
Jul 10, 2023 17:20 ET
TherapeuticsMD | 8-K: Current report
Jul 6, 2023 16:38 ET
No Data
No Data